{"associated_institutions":[],"authors_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4403386525/authors","cited_by_count":46,"collaborators_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4403386525/collaborators","country_code":null,"counts_by_year":[{"cited_by_count":0,"oa_works_count":2,"works_count":2,"year":2019},{"cited_by_count":46,"oa_works_count":1,"works_count":1,"year":2017}],"counts_by_year_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4403386525/counts_by_year","created_date":"2024-10-15T03:13:15.000Z","display_name":"Amgen Biofarmaceutica Lda (Portugal)","display_name_acronyms":[],"display_name_alternatives":["Amgen Biofarmaceutica Lda","Amgen Biofarmaceutica Lda (Portugal)","Amgen Biopharmaceutical"],"geo":{"city":"Paço de Arcos","country":"Portugal","country_code":null,"geonames_city_id":null,"latitude":38.6956901550293,"longitude":-9.291430473327637,"region":null},"homepage_url":"https://www.amgen.pt","id":"https://openalex.org/I4403386525","ids":{"grid":null,"openalex":"https://openalex.org/I4403386525","ror":"https://ror.org/00bc21d89","wikidata":null,"wikipedia":null},"image_thumbnail_url":null,"image_url":null,"is_super_system":false,"lineage":["https://openalex.org/I4403386525"],"repositories":[],"roles":[{"id":"https://openalex.org/I4403386525","role":"institution","works_count":3}],"ror":"https://ror.org/00bc21d89","summary_stats":{"2yr_mean_citedness":0,"h_index":1,"i10_index":1},"topic_share":[{"display_name":"Pharmacovigilance and Adverse Drug Reactions","domain":{"display_name":"Life Sciences","id":"https://openalex.org/domains/1"},"field":{"display_name":"Pharmacology, Toxicology and Pharmaceutics","id":"https://openalex.org/fields/30"},"id":"https://openalex.org/T11943","subfield":{"display_name":"Toxicology","id":"https://openalex.org/subfields/3005"},"value":0.0000255},{"display_name":"Poisoning and overdose treatments","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T11635","subfield":{"display_name":"Emergency Medicine","id":"https://openalex.org/subfields/2711"},"value":0.0000136},{"display_name":"Pharmaceutical Economics and Policy","domain":{"display_name":"Social Sciences","id":"https://openalex.org/domains/2"},"field":{"display_name":"Economics, Econometrics and Finance","id":"https://openalex.org/fields/20"},"id":"https://openalex.org/T11792","subfield":{"display_name":"Economics and Econometrics","id":"https://openalex.org/subfields/2002"},"value":0.0000112},{"display_name":"Healthcare cost, quality, practices","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Health Professions","id":"https://openalex.org/fields/36"},"id":"https://openalex.org/T13555","subfield":{"display_name":"General Health Professions","id":"https://openalex.org/subfields/3600"},"value":0.0000107},{"display_name":"Pharmaceutical Practices and Patient Outcomes","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10496","subfield":{"display_name":"Geriatrics and Gerontology","id":"https://openalex.org/subfields/2717"},"value":0.0000076},{"display_name":"Bone health and osteoporosis research","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10071","subfield":{"display_name":"Orthopedics and Sports Medicine","id":"https://openalex.org/subfields/2732"},"value":0.0000075},{"display_name":"Health Systems, Economic Evaluations, Quality of Life","domain":{"display_name":"Social Sciences","id":"https://openalex.org/domains/2"},"field":{"display_name":"Economics, Econometrics and Finance","id":"https://openalex.org/fields/20"},"id":"https://openalex.org/T10804","subfield":{"display_name":"Economics and Econometrics","id":"https://openalex.org/subfields/2002"},"value":0.0000031}],"topics":[{"count":1,"display_name":"Bone health and osteoporosis research","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10071","score":0.9167,"subfield":{"display_name":"Orthopedics and Sports Medicine","id":"https://openalex.org/subfields/2732"}},{"count":1,"display_name":"Pharmaceutical Practices and Patient Outcomes","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10496","score":0.9997,"subfield":{"display_name":"Geriatrics and Gerontology","id":"https://openalex.org/subfields/2717"}},{"count":1,"display_name":"Health Systems, Economic Evaluations, Quality of Life","domain":{"display_name":"Social Sciences","id":"https://openalex.org/domains/2"},"field":{"display_name":"Economics, Econometrics and Finance","id":"https://openalex.org/fields/20"},"id":"https://openalex.org/T10804","score":0.9995,"subfield":{"display_name":"Economics and Econometrics","id":"https://openalex.org/subfields/2002"}},{"count":1,"display_name":"Poisoning and overdose treatments","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T11635","score":0.9942,"subfield":{"display_name":"Emergency Medicine","id":"https://openalex.org/subfields/2711"}},{"count":1,"display_name":"Pharmaceutical Economics and Policy","domain":{"display_name":"Social Sciences","id":"https://openalex.org/domains/2"},"field":{"display_name":"Economics, Econometrics and Finance","id":"https://openalex.org/fields/20"},"id":"https://openalex.org/T11792","score":0.9976,"subfield":{"display_name":"Economics and Econometrics","id":"https://openalex.org/subfields/2002"}},{"count":1,"display_name":"Pharmacovigilance and Adverse Drug Reactions","domain":{"display_name":"Life Sciences","id":"https://openalex.org/domains/1"},"field":{"display_name":"Pharmacology, Toxicology and Pharmaceutics","id":"https://openalex.org/fields/30"},"id":"https://openalex.org/T11943","score":0.9993,"subfield":{"display_name":"Toxicology","id":"https://openalex.org/subfields/3005"}},{"count":1,"display_name":"Healthcare cost, quality, practices","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Health Professions","id":"https://openalex.org/fields/36"},"id":"https://openalex.org/T13555","score":0.9693,"subfield":{"display_name":"General Health Professions","id":"https://openalex.org/subfields/3600"}}],"type":"company","type_id":"https://openalex.org/institution-types/company","updated_date":"2026-02-06T19:53:56.000Z","works_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4403386525/works","works_count":3}